EN | TH

Product Research and Development and Innovation Creation

Product Research and Development and Innovation Creation

Supporting the SDGs Goals

Goal 3:
Good Health and Well-Being
Goal 9:
Industry, Innovation and Infrastructure
Goal 12:
Responsible Consumption and Production

Stakeholders Directly Impacted

Customers/Consumers
Business Partners
Regulatory Agencies
Competitors

Goals and Performance Highlights

Goals
New products in the new generic drug category can be marketed
At least products per year
Herbal product formulations approved by the company’s internal committee
At least products per year
Formulations with reduced or no use of environmentally unfriendly organic solvents approved by the internal committee
At least products per year
Secondary packaging should be environmentally friendly
At least % by 2030
Number of QCC topics per year
At least topics
Number of Kaizen topics per year
At least topics
Total savings of no less than
baht
Performance Highlights 2025
Innovation in the new generic drug category has resulted in 2 new products and 1 new product was launched in the new generic drug category.
1 product
1 innovative herbal product has been developed and herbal product formulation was approved by the Company’s internal committee.
product
At least %
of secondary packaging should be environmentally friendly in 2025.
At least 10 product formulations
with reduced or eliminated environmentally unfriendly organic solvents have been approved by the internal committee.
Total savings
baht
QCC topics
items
Kaizen topics
items
ESG Performance Data

Commitment, Challenge and Opportunity

Research and development is a crucial process that helps increase opportunities for obtaining a diverse range of medicines and health products, which can better meet consumer demands. Expanding the product range not only helps to broaden the consumer base but also designing research and development processes that minimize potential environmental impact is a key factor influencing consumer decision-making today. Additionally, integrating various technologies or innovations into research and development will enhance market competitiveness, create uniqueness, and provide more options for consumers. Apart from developing innovations for product research and development, creating innovations in work processes is a crucial element that improves work efficiency, enhances employee potential, and fosters continuous development.

Management and Operational Approach

The group places importance on incorporating innovation into research and development as well as work processes by establishing a vision, mission, and corporate values to promote the creation of innovations in both work processes and product development. In 2025, the company will define clearer policies and guidelines regarding the development of corporate innovation.

The group has established the BLC Research Center to conduct research and development of products for both the group and external clients, as well as fostering collaboration with external research organizations, both public and private, to develop innovations in research that result in high-quality work benefiting society, the environment, and trade partners. Additionally, the group has developed a product strategy in its business plan to define the direction for future business operations.

For the development of innovation in work processes, BLC has established a QCC (Quality Control Cycle) system development committee to stimulate and encourage employees to generate creative ideas, as well as developing skills in analysis and problem-solving within work processes.

Sustainability Plan

1
Research and Development of New Products
The group establishes research plans for every product with a clear timeline and budget allocation for research each year. There is a process to request approval of formulations by the internal design committee, which is responsible for assessing the appropriateness of the formulation and production process of the researched products.
2
Research and development of formulations and production processes to reduce environmental impact
In the formulation research and development, consideration has been given to the environmental impact, consumers, and workers. Over the past years, the company has adjusted the use of solvents in several product formulations by replacing organic solvents with water-based solvents. In 2024, the company continues to research and develop formulations without using organic solvents or by reducing their usage as much as possible.
3
Use of environmentally friendly packaging
The group has started transitioning to environmentally friendly packaging, focusing on secondary packaging that does not come into direct contact with the product and does not affect product quality. Consideration includes material selection, print design, and the packaging production process by manufacturers. The company has switched to paper packaging materials that help reduce environmental impact, including paper made from recycled materials
4
Work improvement and efficiency enhancement through QCC and Kaizen
The QCC (Quality Control Cycle) System Development Committee organized employee participation activities through QCC groups and Kaizen activities, including competitions with cash prizes.

Operational Achievements in 2025

Key Performance Indicators (KPIs) 2025 Performance Results
  • Innovation in the new generic drug group will be developed with no less than 2 products per year.
  • At least 1 new product in the new generic drug category can be marketed per year.
  • At least one innovative herbal product will be developed every two years.
  • At least 1 herbal product formulations approved by the Company’s internal committee per year.
  • At least 2 formulations with reduced or no use of environmentally unfriendly organic solvents approved by the internal committee per year.
  • By 2026, at least 30% of secondary packaging (Secondary Packaging) will be transitioned to environmentally friendly materials.
  • At least 12 QCC topics per year.
  • At least 25 Kaizen topics per year.
  • Total savings of no less than 70,000 baht.

Related Documents

ESG Reporting Library
Company Management System Policies and Objectives
Download
Innovation Development Policy
Download
ESG Reporting Library